Cargando…
Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma
BACKGROUND: Osteosarcoma accounts for roughly 60% of all malignant bone tumors in children and young adults. The five-year survival rate for localized tumors after surgery and chemotherapy is approximately 70% whilst it drastically reduces to 15–30% in metastatic cases. Metabolic modulation is known...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101145/ https://www.ncbi.nlm.nih.gov/pubmed/30140384 http://dx.doi.org/10.18632/oncotarget.25843 |